Om

Klaria Pharma Holding AB (publ.) is a Swedish pharmaceutical company focused on developing and commercializing innovative, fast-acting treatments for migraine and cancer-related pain. Its work is built around a patented drug delivery platform based on an alginate polymer film designed to support rapid transmucosal absorption. The company also maintains a broader pipeline spanning pain-related conditions, opioid overdose, cannabinoids, and allergic shock. Klaria Pharma Holding AB serves the biotechnology and medical research market through therapeutic products intended for areas with clear unmet medical need, combining formulation technology with drug development expertise. Headquartered in Uppsala, Sweden, the company operates through its subsidiaries to advance and commercialize its current pharmaceutical portfolio.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I KLARIA PHARMA HOLDING MED ENDAVU: Køb Klaria Pharma Holding ($6FN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Klaria Pharma Holding, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.